Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Quarterly results
Director departure
Appointed director
CC transcript

DRUGSTORE COM INC (DSCM) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/13/2012 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
06/03/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
06/03/2011 SC 13D/A AMAZON COM INC reports a 0% stake in drugstore.com, inc.
06/03/2011 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
06/03/2011 8-K Quarterly results
05/27/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/27/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "— Proxy Statement Supplement"
05/13/2011 10-Q Quarterly Report for the period ended April 3, 2011
05/10/2011 4 Steeb James Orville (Pres & CEO, Salu Beauty, Inc.) has filed a Form 4 on DRUGSTORE COM INC
05/09/2011 PRN drugstore.com Announces Expiration of HSR Waiting Period for the Proposed Walgreens Merger
05/09/2011 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "drugstore.com Announces Expiration of HSR Waiting Period for the Proposed Walgreens Merger"
05/02/2011 10-K/A Annual Report for the period ended January 2, 2011 [amend]
04/29/2011 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition
04/28/2011 8-K Form 8-K - Current report
04/28/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/13/2011 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition
04/13/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amendment to Dawn Lepore Offer Letter, by and between drugstore.com, inc. and Dawn Lepore",
"Form of Employee Q&A",
"Form of Notice regarding Employee Equity Holdings",
"Form of Notice to Holders of Stock Options and Stock Appreciation Rights",
"Form of Notice to Holders of Restricted Stock",
"Form of Notice to Holders of Restricted Stock Units"
04/13/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
04/12/2011 BW Branam Oral Health Announces New Distribution Deal with drugstore.com
04/06/2011 4 Wright Tracy Lynn (VP, Chief Finance Officer) has filed a Form 4 on DRUGSTORE COM INC
04/06/2011 4 Potter Robert Presley (VP, Chief Accounting Officer) has filed a Form 4 on DRUGSTORE COM INC
04/06/2011 4 Pavlovsky Stan (VP, Vision Direct) has filed a Form 4 on DRUGSTORE COM INC
04/06/2011 4 Morikubo Yukio (VP, Strategy, Gen Couns & Sec) has filed a Form 4 on DRUGSTORE COM INC
04/06/2011 4 McNeill Kathleen McKey (VP, Beauty) has filed a Form 4 on DRUGSTORE COM INC
04/06/2011 4 Lonczak David Lawrence (VP, Chief Marketing Officer) has filed a Form 4 on DRUGSTORE COM INC
04/06/2011 4 LEPORE DAWN G (CEO, Pres + Chairman of Board) has filed a Form 4 on DRUGSTORE COM INC
04/06/2011 4 Kelly Ronald Eugene (VP, Customer & Pharmacy Ops) has filed a Form 4 on DRUGSTORE COM INC
04/06/2011 4 Johnston Julie Anne (VP, OTC Merchandising) has filed a Form 4 on DRUGSTORE COM INC
04/06/2011 4 Axelsson Jon Clarence (VP, Operations) has filed a Form 4 on DRUGSTORE COM INC
03/30/2011 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/29/2011 4 McNeill Kathleen McKey (VP, Beauty) has filed a Form 4 on DRUGSTORE COM INC
03/29/2011 4 Lonczak David Lawrence (VP, Chief Marketing Officer) has filed a Form 4 on DRUGSTORE COM INC
03/28/2011 SC 13D/A DISCOVERY EQUITY PARTNERS, LP reports a 0% stake in drugstore.com, inc.
03/25/2011 BW Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Drugstore.com Inc. - DSCM
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy